129 related articles for article (PubMed ID: 30932685)
21. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
[TBL] [Abstract][Full Text] [Related]
22. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors in adenocarcinoma of the colon and rectum].
Yoshimura H; Yamagiwa H
Gan No Rinsho; 1985 Jul; 31(8):937-43. PubMed ID: 2993697
[TBL] [Abstract][Full Text] [Related]
24. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer.
Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W
Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912
[TBL] [Abstract][Full Text] [Related]
25. The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).
Huang KC; Chiang SF; Ke TW; Chen WT; Chen TW; Chao KC
Cancer Genomics Proteomics; 2020; 17(3):291-299. PubMed ID: 32345670
[TBL] [Abstract][Full Text] [Related]
26. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
27. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
28. Influence of pT3 subgroups on outcome of R0-resected colorectal tumors.
Mrak K; Jagoditsch M; Leibl S; Klingler A; Tschmelitsch J
South Med J; 2011 Nov; 104(11):722-30. PubMed ID: 22024778
[TBL] [Abstract][Full Text] [Related]
29. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
[TBL] [Abstract][Full Text] [Related]
30. Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients.
Wyss J; Dislich B; Koelzer VH; Galván JA; Dawson H; Hädrich M; Inderbitzin D; Lugli A; Zlobec I; Berger MD
Clin Colorectal Cancer; 2019 Mar; 18(1):e20-e38. PubMed ID: 30389315
[TBL] [Abstract][Full Text] [Related]
31. Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis.
Lee H; Choi DW; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi SH; Jung KU; Chun HK
Ann Surg Oncol; 2014 May; 21(5):1641-6. PubMed ID: 24496602
[TBL] [Abstract][Full Text] [Related]
32. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
33. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Chen XY; Zhang J; Hou LD; Zhang R; Chen W; Fan HN; Huang YX; Liu H; Zhu JS
Int J Immunopathol Pharmacol; 2018; 32():2058738418790318. PubMed ID: 30045644
[TBL] [Abstract][Full Text] [Related]
35. A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum.
Smith JD; Reidy DL; Goodman KA; Shia J; Nash GM
Ann Surg Oncol; 2014 Sep; 21(9):2956-62. PubMed ID: 24763982
[TBL] [Abstract][Full Text] [Related]
36. KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.
Lee DW; Kim KJ; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Ann Surg Oncol; 2015 Jan; 22(1):187-94. PubMed ID: 24889488
[TBL] [Abstract][Full Text] [Related]
37. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
[TBL] [Abstract][Full Text] [Related]
38. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
[TBL] [Abstract][Full Text] [Related]
39. The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.
Alberda WJ; Verhoef C; Schipper ME; Nuyttens JJ; Rothbarth J; de Wilt JH; Burger JW
Dis Colon Rectum; 2015 Jul; 58(7):677-85. PubMed ID: 26200682
[TBL] [Abstract][Full Text] [Related]
40. Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria.
Landau MA; Zhu B; Akwuole FN; Pai RK
Int J Surg Pathol; 2019 Apr; 27(2):147-158. PubMed ID: 29992847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
